Diabetes Mellitus
📧 Sign up to get email alerts when something new happens for Diabetes Mellitus.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2014-01-24FDA Approved: HUMALOG MIX75/25 — Supplemental Application (Eli Lilly and Company)
The FDA approved a supplemental application for Humalog Mix75/25 (insulin lispro) from Eli Lilly. This action approves a supplemental submis…
-
FDA approval · 2014-01-24FDA Approved: HUMALOG MIX50/50 KWIKPEN — Supplemental Application (Eli Lilly and Company)
FDA approved a supplemental application for HUMALOG MIX50/50 KWIKPEN (insulin lispro) by Eli Lilly and Company.
-
CLINICAL_TRIALS research · 2014-01-24Clinical Trial Update: Medical Record Study on Adverse Events Requiring a Higher Level of Care in Flemish Hospitals
Completed clinical trial update describing a medical-records study conducted in Flemish hospitals that examined adverse events requiring esc…
-
CLINICAL_TRIALS trial_result · 2014-01-23Clinical Trial Update: Dipeptidyl Peptidase-4 Inhibition and Immune Function in HIV [Phase 2, Phase 3]
Phase 2/3 trial evaluating DPP-4 inhibition and immune function in HIV patients with diabetes and insulin resistance; results were posted in…
-
CLINICAL_TRIALS trial_result · 2014-01-23Clinical Trial Update: Aerobic Training and Arterial Stiffness in Chronic Kidney Disease (CKD) Patients [NA]
A completed clinical trial examines the effect of aerobic training on arterial stiffness in patients with chronic kidney disease, including …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2014-01-17Clinical Trial Update: A Study of Xuebi Formula for Diabetic Peripheral Neuropathy(Qi-deficiency and Blood-stasis) [NA]
This clinical trial update describes a study of Xuebi Formula for diabetic peripheral neuropathy, with diabetes as a co-condition; the trial…
-
FDA approval · 2014-01-15FDA Approved: HUMULIN 70/30 — Supplemental Application (Eli Lilly and Company)
The FDA approved a supplemental application for HUMULIN 70/30 (insulin human) from Eli Lilly and Company.
-
FDA approval · 2014-01-15FDA Approved: HUMULIN N — Supplemental Application (Eli Lilly and Company)
The FDA approved Eli Lilly's supplemental application for Humulin N (insulin human), approving changes to the product labeling.
-
CLINICAL_TRIALS withdrawal · 2014-01-15Clinical Trial Update: Comparison of the Effect of Intense-Exercise/Moderate-Calorie, Topiramate-Phentermine and Cognitive Behavioral Therapy on Obesity [NA]
A clinical trial comparing intense exercise with moderate calorie intake, a topiramate/phentermine pharmacologic regimen, and cognitive beha…
-
CLINICAL_TRIALS trial_result · 2014-01-09Clinical Trial Update: Effects of Lifestyle Education Programs on Diabetes Control in Rwanda [NA]
A completed clinical trial evaluating the impact of lifestyle education programs on diabetes control in Rwanda.
-
CLINICAL_TRIALS research · 2014-01-07Clinical Trial Update: Influence of Coffee on the Health and on the Heart of Normal, Diabetics e Coronary Artery Disease Patients
A University of Sao Paulo clinical trial investigates how coffee consumption affects health and heart function in healthy individuals, diabe…
-
CLINICAL_TRIALS trial_result · 2014-01-06Clinical Trial Update: A Trial Investigating the Pharmacokinetics and Pharmacodynamics of NNC0123-0000-0338 in a Tablet Formulation With Three Different Coatings in Healthy Subjects [Phase 1]
Phase 1 trial evaluating the pharmacokinetics and pharmacodynamics of the tablet formulation NNC0123-0000-0338 with three coatings in health…
-
CLINICAL_TRIALS trial_result · 2014-01-06Clinical Trial Update: Insulin Dosage Software Program for People With Type 1 and Type 2 Diabetes [NA]
A completed clinical trial study evaluating an insulin dosage software program for people with type 1 and type 2 diabetes; results posted in…
-
CLINICAL_TRIALS trial_result · 2013-12-31Clinical Trial Update: Glycemic Control and Variability for Congestive Heart Failure Exacerbation [Phase 1, Phase 2]
Phase 1/Phase 2 clinical trial assessing glycemic control and glycemic variability in patients with congestive heart failure exacerbation; r…
-
CLINICAL_TRIALS research · 2013-12-30Clinical Trial Update: Study To Assess the Dietary Carbohydrate Content of Indian Diabetic Population
A Bayer-sponsored clinical trial evaluating dietary carbohydrate content in the Indian diabetic population has completed.
-
CLINICAL_TRIALS trial_result · 2013-12-20Clinical Trial Update: Effect of Pomegranate Extract Intake on Body Composition and Blood Pressure. [NA]
A clinical trial evaluating the effects of pomegranate extract intake on body composition and blood pressure in individuals with obesity, di…
-
CLINICAL_TRIALS trial_result · 2013-12-18Clinical Trial Update: The Effect of Potato Fries Processing on Food Intake, Satiety and Blood Glucose [NA]
A completed clinical trial evaluated the effect of potato fries processing on food intake, satiety, and blood glucose in adults with obesity…
-
CLINICAL_TRIALS trial_result · 2013-12-18Clinical Trial Update: The Food Intake, Satiety and Blood Glucose After Ingestion of Potato Chips Produced From Three Potato Cultivars [NA]
Completed trial evaluating how potato chips from three cultivars influence food intake, satiety, and postprandial blood glucose. The study e…
-
CLINICAL_TRIALS trial_result · 2013-12-17Clinical Trial Update: Single Dose, Single Administration Study of Technosphere Inhalation Powder in Diabetic Subjects With Mild or Moderate Kidney Disease Compared to Diabetic Subjects With Normal Kidney Function [Phase 1]
A Phase 1 single-dose study evaluating Technosphere Inhalation Powder (inhaled insulin) in diabetic subjects with mild or moderate nephropat…
-
CLINICAL_TRIALS trial_result · 2013-12-17Clinical Trial Update: Trial Comparing Metabolic Effects of Telmisartan and Amlodipine on Hypertensive Patients With Obesity and Diabetes [Phase 4]
This update reports the completion of a Phase 4 trial comparing the metabolic effects of telmisartan and amlodipine in hypertensive patients…
-
CLINICAL_TRIALS trial_result · 2013-12-16Clinical Trial Update: Improvement of Sensibility in the Foot in Diabetic Patients Induced by EMLA-application to the Lower Leg [Phase 3]
Phase 3 clinical trial investigating whether applying EMLA cream to the lower leg improves foot sensibility in people with diabetes has comp…
-
CLINICAL_TRIALS guidance · 2013-12-16Clinical Trial Update: Standardized Procedure for the Assessment of New-to-market Continuous Glucose Monitoring Systems [NA]
This clinical trial update describes a standardized procedure for evaluating new-to-market continuous glucose monitoring systems.
-
FDA approval · 2013-12-12FDA Approved: HUMULIN 70/30 — Supplemental Application (Eli Lilly and Company)
The FDA approved a supplemental application for HUMULIN 70/30 (insulin human) from Eli Lilly and Company.
-
FDA approval · 2013-12-12FDA Approved: HUMALOG MIX75/25 — Supplemental Application (Eli Lilly and Company)
The FDA approved a supplemental application for Humalog Mix75/25 (insulin lispro) from Eli Lilly and Company.
-
CLINICAL_TRIALS trial_result · 2013-12-12Clinical Trial Update: A Low-Carbohydrate, Ketogenic Diet Versus Orlistat for Weight Loss [NA]
A completed clinical trial compared a low-carbohydrate ketogenic diet with the drug Orlistat for weight loss in adults with diabetes mellitu…